Wrath of the Righteous and Warhammer 40,000: Rogue Trader — together with Alcon Interactive Group revealed a selection of new ...

Alcon showcases new data at APACRS 2025, emphasizing advancements in IOL technology and surgical precision for improved ...

Tom McDonald worked at Alcon for nearly four decades and writes about the eyecare giant's remarkable growth that started in ...

We recently published 10 Stocks Crash as AI Glow Fades. Alcon Inc. (NYSE:ALC) is one of Wednesday’s worst performers. Shares of Alcon Inc. snapped a six-day winning streak on Wednesday, losing 10.07 ...

Alcon (NYSE:ALC) stock continues to decline as J.P. Morgan downgrades the company following mixed Q2 2025 results and lowered sales guidance. Read more here.

Alcon affirmed fiscal year 2025 adjusted earnings of $3.05-$3.15 versus consensus of $3.12. The company lowered 2025 sales guidance from $10.4 billion-$10.5 billion to $10.3 billion-$10.4 billion, ...

Baird analyst Jeff Johnson lowered the firm’s price target on Alcon (ALC) to $95 from $108 and keeps an Outperform rating on the shares. The frim ...

The analysts cut its rating on Alcon shares to “neutral” from “overweight” and lowered its price target to SFr 62.8 for June 2027, down from SFr 94.7 for June 2026. The reduced target reflects lower ...

Alcon India unveils UNITY VCS and UNITY CS with superior efficiency for vitreoretinal and cataract surgery: Our Bureau, Bengaluru Thursday, August 21, 2025, 14:40 Hrs [IST] Alcon, ...

Alcon Inc (ALC) reports steady revenue growth and strategic acquisitions, despite facing market pressures and competitive challenges.

In a report released today, Graham Doyle from UBS maintained a Buy rating on Alcon, with a price target of CHF100.00. The company’s shares closed yesterday at $90.12. Take advantage of TipRanks ...

The latest health news covers underwhelming results from Viking's weight-loss pill, potential tax exemptions on health insurance in India, Brazil's declining chicken exports due to bird flu, U.S.